Recent Insider Transactions - TScan Therapeutics (NASDAQ: TCRX)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ TCRX TScan Therapeutics

Lynx1 Capital Management LP / 10 percent owner

12/13/2024

Buy

$2.90

100,000

$290K

5.36M

NASDAQ TCRX TScan Therapeutics

Lynx1 Capital Management LP / 10 percent owner

12/12/2024

Buy

$3.01

31,800

$96K

5.26M

NASDAQ TCRX TScan Therapeutics

Lynx1 Capital Management LP / 10 percent owner

11/15/2024

Buy

$4.34

947

$4K

5.23M